This site is intended for healthcare professionals

GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers Symposium.

Read time: 1 mins
Last updated:28th Jun 2021
Published:19th Jan 2021
Condition: Mismatch Repair Deficient Non Endometrial Tumours
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest